-+ 0.00%
-+ 0.00%
-+ 0.00%

Gilead Sciences Swings to 2Q Loss on R&D Costs, HIV-Drug Sales Lift Revenue

Dow Jones·08/04/2026 20:08:00

Please log in to view news